By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Novartis International AG 

Lichtstrasse 35

Basel    CH-4056  Switzerland
Phone: 41-61-324-1111 Fax: 41-61-324-8001



Company News
Novartis International AG (NVS) Presents Key Advances In Cancer Research At American Society of Clinical Oncology And European Hematology Association From Four New Pivotal Studies In Lung, Blood And Skin Cancers 5/22/2014 10:50:12 AM
Novartis International AG (NVS) (JOBS) to Invest $1 Billion in China 11/3/2009 7:20:52 AM
Novartis International AG (NVS) Says on Track to Deliver US Vaccine Order 10/29/2009 9:53:19 AM
Novartis International AG (NVS) Says EU Approves Inflammatory Disease Drug 10/28/2009 8:27:25 AM
Novartis International AG (NVS) Says Glivec Has Potential to Treat PAH; Drug Did Not Reach Statistical Significance In Main Target 10/8/2008 7:48:50 AM
MorphoSys AG to Host Conference Call to Discuss New Strategic Alliance With Novartis 12/3/2007 11:38:55 AM
CIBA Vision Corporation (NVS), the Eye Care Unit of Novartis International AG (NVS), Announces Settlement of Patent Litigation with CooperVision, Inc. 11/21/2007 1:13:05 PM
New Safety Issues to Delay Novartis International AG (NVS)'s Galvus 11/6/2007 6:52:48 AM
Novartis International AG (NVS) Proposes Changes to Galvus Prescribing 11/6/2007 12:38:56 AM
Novartis International AG (NVS) Says U.S. Approves Tasigna Cancer Drug 10/30/2007 7:30:35 AM